Echo Street Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,530
Closed -$582K 157
2023
Q3
$582K Buy
8,530
+4,332
+103% +$368K 0.01% 230
2023
Q2
$394K Sell
4,198
-6,173
-60% -$482K ﹤0.01% 331
2023
Q1
$703K Buy
10,371
+3,046
+42% +$196K 0.01% 184
2022
Q4
$363K Buy
+7,325
New +$299K ﹤0.01% 370
2022
Q3
Sell
-26,745
Closed -$1.05M 598
2022
Q2
$1.05M Buy
26,745
+16,493
+161% +$882K 0.01% 167
2022
Q1
$717K Buy
+10,252
New +$749K 0.01% 313
2021
Q4
Sell
-4,967
Closed -$474K 668
2021
Q3
$474K Buy
+4,967
New +$524K ﹤0.01% 432

Other funds holding EXAS

Echo Street Capital Management's EXAS Position: Q4 2023 in Review

Echo Street Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 8,530 shares — an estimated $582K sold.

Echo Street Capital Management first reported a position in EXAS in Q3 2021 and held it in 7 quarters. The position peaked at $1.05M in Q2 2022. 648 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Echo Street Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 8,530 Exact Sciences shares in Q4 2023, an estimated $582K.
  • Echo Street Capital Management first reported a position in Exact Sciences in Q3 2021 and held it in 7 quarters.
  • Echo Street Capital Management's Exact Sciences position peaked at $1.05M in Q2 2022.
  • 648 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.